By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Circassia Pharma 

Northbrook House
Robert Robinson Avenue
The Oxford Science Park  Oxford  OX4 4GA  United Kingdom
Phone: n/a Fax: n/a



Start Up

Company News
Circassia (CIR.L) Announces Duaklir Successfully Met Primary Endpoints In AMPLIFY Phase III Study In Chronic Obstructive Pulmonary Disease 9/7/2017 6:53:18 AM
Circassia (CIR.L) Finally Throws In The Towel On Allergy Program After Trial Failures 4/18/2017 6:35:14 AM
Circassia (CIR.L) Surges After Scoring $300 Million Respiratory R&D Deal With AstraZeneca PLC (AZN) 3/17/2017 5:46:42 AM
Circassia (CIR.L) Stock Crashes as Allergy Drug Flunks Crucial Phase III Study 6/20/2016 6:50:42 AM
ERT Integrates Circassia (CIR.L)’s FeNO Device to Assess Patient Airway Inflammation 5/18/2016 8:33:44 AM
Circassia (CIR.L) Announces Positive Outcome Of European Decentralised Procedure For Approval Of Its Fluticasone Propionate Equivalent Of GlaxoSmithKline (GSK)’s FLIXOTIDE pMDI 11/24/2015 10:19:19 AM
Circassia (CIR.L) Business Update 10/27/2015 12:18:48 PM
Circassia (CIR.L) Release: Interim Results For The Six Months Ended 30 June 2015 7/28/2015 8:50:12 AM
Circassia (CIR.L)’s Extended Offer Period For Aerocrine Has Increased Acceptances To 97.2 Percent 6/30/2015 9:28:55 AM
Circassia (CIR.L) Release: Completion Of Acquisition Of Prosonix 6/15/2015 10:18:50 AM